Table 3.
Tumor uptake and dose in groups
| Groups | Characteristics | MAA | 90Y | p | |
|---|---|---|---|---|---|
| ARC n=115 | T/NL | Median (IQR) | 1.74 (1.43) | 2.16 (2.15) | <0.001* |
| Dose (Gy) | Median (IQR) | 73.72 (62.82) | 90.96 (98.31) | <0.001* | |
|
| |||||
| Control n=75 | T/NL | Median (IQR) | 1.60 (2.04) | 1.57 (1.38) | 0.892 |
| Dose (Gy) | Median (IQR) | 72.92 (80.33) | 66.88 (87.71) | 0.950 | |
MAA, macroaggregated albumin; ARC, antireflux catheter; IQR, interquartile range; T/NL, tumor to normal liver uptake.
Wilcoxon signed rank test was used for the analysis of patient-paired difference between MAA and 90Y.
*
Indicates a significant result at a 5% type I error.